These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1864575)

  • 21. Clozapine, cognition, and schizophrenia.
    Launer M
    Br J Psychiatry; 1993 Apr; 162():567-8. PubMed ID: 8481757
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical efficacy of clozapine in the treatment of schizophrenia.
    Meltzer HY; Alphs LD; Bastani B; Ramirez LF; Kwon K
    Pharmacopsychiatry; 1991 Mar; 24(2):44-5. PubMed ID: 1852789
    [No Abstract]   [Full Text] [Related]  

  • 23. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
    J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight gain among schizophrenic patients treated with clozapine.
    Lamberti JS; Bellnier T; Schwarzkopf SB
    Am J Psychiatry; 1992 May; 149(5):689-90. PubMed ID: 1349460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges.
    VanderZwaag C; McGee M; McEvoy JP; Freudenreich O; Wilson WH; Cooper TB
    Am J Psychiatry; 1996 Dec; 153(12):1579-84. PubMed ID: 8942454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 27. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
    Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
    Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone response after no clozapine response.
    Avnon M; Kunin A
    Br J Psychiatry; 1995 Nov; 167(5):699. PubMed ID: 8564340
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.
    Miller DD; Fleming F; Holman TL; Perry PJ
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():117-21. PubMed ID: 7961554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    Schooler NR; Marder SR; Chengappa KN; Petrides G; Ames D; Wirshing WC; McMeniman M; Baker RW; Parepally H; Umbricht D; Kane JM
    J Clin Psychiatry; 2016 May; 77(5):628-34. PubMed ID: 27035871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine and electroconvulsive therapy.
    Fink M
    Arch Gen Psychiatry; 1990 Mar; 47(3):290-1. PubMed ID: 1968331
    [No Abstract]   [Full Text] [Related]  

  • 32. Can clozapine response be predicted? A naturalistic pilot study.
    Fenton WS; Lee B
    J Nerv Ment Dis; 1993 Jan; 181(1):62-4. PubMed ID: 8419518
    [No Abstract]   [Full Text] [Related]  

  • 33. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine: is another view valid?
    Meltzer HY
    Am J Psychiatry; 1995 Jun; 152(6):821-5. PubMed ID: 7755109
    [No Abstract]   [Full Text] [Related]  

  • 35. Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Pandolfo G; Micò U; Lamberti Castronuovo E; Abenavoli E; Scimeca G; Spina E; Zoccali R; Bruno A
    J Clin Psychopharmacol; 2014 Feb; 34(1):129-33. PubMed ID: 24145221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.
    Potkin SG; Bera R; Gulasekaram B; Costa J; Hayes S; Jin Y; Richmond G; Carreon D; Sitanggan K; Gerber B
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():133-6. PubMed ID: 7961557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine concentrations and clinical response in schizophrenic patients.
    Owen JA; Delva NJ; Lawson JS
    Am J Psychiatry; 1992 Aug; 149(8):1120-1. PubMed ID: 1636820
    [No Abstract]   [Full Text] [Related]  

  • 39. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
    Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
    Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.